MiMedx Provides Update On Illegal Short Selling Activities Against The Company

January 5, 2018

Responsive image

MARIETTA, Ga., Jan. 5, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing proprietary human placental tissue allografts, today provided answers to certain questions being…

Category: Precious Metals